Peroxynitrite decreases hemostasis in Human plasma in vitro

Vance G. Nielsen, John P. Crow, Ashish Mogal, Fen Zhou, Dale A. Parks

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Coagulopathy has been associated with clinical scenarios that involve reactive nitrogen species such as peroxynitrite (OONO-). Further, OONO- decreases tissue factor and fibrinogen function in vitro. Thus, we hypothesized that exposure of plasma to the OONO- generated with 3-morpholinosydnonimine (SIN-1), a molecule that produces both nitric oxide and superoxide, would result in a decrease in hemostatic function via diminished coagulation protein activity. Hemostatic function of plasma exposed to SIN-1 (0, 1, 5, and 10 mM for 60 min at 37°C) was assessed with thrombelastography, activated partial thromboplastin time, and prothrombin time in the presence or absence of superoxide dismutase (SOD) or an OONO- scavenger. SIN-1 exposure resulted in a significant (P < 0.05), dose-dependent decrease in plasma hemostatic function and concurrent significant (P < 0.05) decreases in activities of factor VII, factor VIII complex, and factor X. Fibrinogen concentration was not affected by SIN-1. Antithrombin and protein C activity also decreased significantly (P < 0.05). Coincubation with SOD or an OONO- scavenger significantly (P < 0.05) attenuated SIN-1 mediated changes in hemostasis and procoagulant/anticoagulant activity. We conclude that OONO- may decrease hemostatic function in human plasma by nitration of key procoagulants and that OONO- may play a significant role in hemorrhagic states.

Original languageEnglish (US)
Pages (from-to)21-26
Number of pages6
JournalAnesthesia and analgesia
Issue number1
StatePublished - Jul 2004

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Peroxynitrite decreases hemostasis in Human plasma in vitro'. Together they form a unique fingerprint.

Cite this